1. Home
  2. WORX vs OGEN Comparison

WORX vs OGEN Comparison

Compare WORX & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

N/A

Current Price

$0.15

Market Cap

4.3M

ML Signal

N/A

Logo Oragenics Inc.

OGEN

Oragenics Inc.

N/A

Current Price

$0.94

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WORX
OGEN
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.6M
IPO Year
2016
2010

Fundamental Metrics

Financial Performance
Metric
WORX
OGEN
Price
$0.15
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.7M
481.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
79.79
82.57
EPS
N/A
N/A
Revenue
$2,989,599.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.11
52 Week High
$1.37
$9.16

Technical Indicators

Market Signals
Indicator
WORX
OGEN
Relative Strength Index (RSI) 37.85 61.36
Support Level N/A $0.78
Resistance Level $0.23 $0.97
Average True Range (ATR) 0.05 0.11
MACD -0.02 0.02
Stochastic Oscillator 8.93 66.06

Price Performance

Historical Comparison
WORX
OGEN

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: